Prophylaxis in real life scenarios-Reference-Cited by-同舟云学术

Prophylaxis in real life scenarios

Published:2014-04-25 Issue: Volume:20 Page:106-113
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Fischer K.¹²,Konkle B.³,Broderick C.⁴⁵,Kessler C. M.⁶

Affiliation:

1. Van Creveldkliniek; University Medical Center Utrecht; Utrecht The Netherlands

2. Julius Center for Health Sciences and Primary Care; University Medical Center Utrecht; Utrecht The Netherlands

3. Puget Sound Blood Center; University of Washington School of Medicine; Seattle WA USA

4. School of Medical Sciences; University of New South Wales; Sydney NSW Australia

5. Children's Hospital Institute of Sports Medicine at Westmead; Sydney NSW Australia

6. Lombardi Comprehensive Cancer Center and the Comprehensive Hemophilia and Thrombosis Treatment Center; Georgetown University Medical Center; Washington DC USA

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12425/fullpdf

Reference77 articles.

1. Haemophilia prophylaxis in Sweden;Nilsson;Acta Paediatr Scand,1976

2. Twenty-five years’ experience of prophylactic treatment in severe haemophilia A and B;Nilsson;J Intern Med,1992

3. Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy;Fischer;Haemophilia,2001

4. On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome;Steen Carlsson;Haemophilia,2003

5. Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life;Khawaji;Eur J Haematol,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients;Medicina;2023-12-24

2. Association of physical activity with bleeding events and safety in patients with haemophilia A starting emicizumab prophylaxis: an interim analysis of the TSUBASA study;International Journal of Hematology;2023-12-15

3. The frequency of complications in a cohort of patients diagnosed with hemophilia A and hemophilia B receiving prophylactic treatment in Colombia: A retrospective noninterventional study;PLOS ONE;2023-11-27

4. Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Real Life: One-Year Clinical and Economic Outcomes;Drugs - Real World Outcomes;2021-06-25

5. Consenso de hemofilia en México;Gaceta de M�xico;2021-04-09